Executive Management

  • Thirty years of experience in drug and CRO industries holding positions across commercial, clinical and consulting domains
  • In 2004 founded AVOS Life Sciences, a healthcare advisory firm with a focus on corporate and outsourcing strategy as well as R&D efficiency; sold AVOS in 2002 to INC Research
  • At INC Research was responsible for all commercial and consulting activities
  • Board Member for INC Research 2004-2006, Chairman 2006-2010
  • Joined Quintiles in 1999 as member of Executive Committee; responsible for corporate and business development activities as well as managing the Global Commercialization Business of Quintiles (Innovex)
  • Has more than 25 years of experience in the research technology, healthcare and life sciences industries.
  • Former CEO of Etrials Worldwide providing eclinical technology to the research and pharmaceutical community until engineering its sale to Merge Healthcare.
  • Served as an executive at GMA Healthcare improving all aspects of operational execution and profitability.
  • Denis has served as an executive management consultant at Infina Connect and several other life science, IT and services companies.
  • He received his MBA from the University of Chicago
  • Dr. Jay has worked in Pain Medicine since 1980 working with Pharma as a consultant, PI and KOL and private practitioner for the first 25 years of his professional career.
  • He was one of the original thirty founding members of the American Academy of Algology, now the American Academy of Pain Medicine in 1983, which helped to develop the subspecialty of Pain Medicine.
  • Founding member and development partner of the American Academy of Pain Management, starting in 1988 and spent the majority of his professional career working with and supporting this organization.
  • He has multiple certifications including Neuro-Rehabilitation and Forensic Medicine, and wrote the diagnostic and treatment algorithms of Chronic benign Pain, Complex Regional Pain Syndrome and Mild Traumatic Brain Injury, which were passed into law by the State of Colorado.
  • Gary founded and was the first president of the Southern California Pain Society (1981), has served on the Board of Directors of the American Association for the Study of Headache, now the American Headache Society- 1988-1990, and is President of the Eastern Pain Association (Dec. 8, 2012- Present).
  • He has published over 120 medical articles in peer reviewed journals dealing with headache, pain of all types, the autonomic nervous system and mild traumatic brain injury as well as medical textbook chapters for books that were not his. He has published 5 textbooks.
  • Former Medical Director at Schwarz/UCB Pharma and Clinical Disease Area Expert-Pain at Pfizer. At INC Research he was Senior Strategist, CNS and Senior Medical Director. He has also served as Chief Medical officer at Archimedes Pharmaceuticals and RAPID Pharmaceuticals.
  • Thirty-five years of global corporate and entrepreneurial operating, senior management and consulting experience. Includes key strategic and operational input into the development, regulatory strategy, and the clinical trial manufacturing process for novel and generic ophthalmic anti- inflammatory, anti-allergic and dry eye pharmaceutical products, wound care, medical devices and diagnostics and clinical trials.
  • Established, led and grew Medical Device, Diagnostics and Ophthalmology Unit for INC Research – a global CRO as Principal Strategist resulting in 240% of corporate goal for awards. Liaison to scientific and investigator community as well as internal resource.
  • Chairman and Chief Science Officer for development and commercialization of first eye-color changing soft contact lens. Product and regulatory breakthrough. Grew from four people to over 200. R&D development investment.
  • C-Level experience with growth oriented pharmaceutical development, manufacturing and distribution company. Supervision of all functions including Ophthalmology Drug Development and Medical Device and Development, Global Regulatory strategies, and manufacturing scale up
  • Bausch & Lomb as Director of Clinical Research – Established the basis for the development of the first thin “breathing” soft contact lens. Revolutionized design and rationale for fitting soft contact lenses regarding safety and clear vision.
  • Subject Matter Expert and Pioneer in Ocular Surface Disease and several “first to approval” ophthalmology, device and diagnostics products.
  • Overall responsibility for regulatory affairs and compliance activities on a global basis.
  • 30 years’ experience in clinical, regulatory, government affairs for the analytic, medical device and pharmaceutical industry.
  • Dir. of Research for the NCADD NJ as well as MhARIA (NGO in Africa).
  • CEO / VP of Regulatory and Clinical Research for Advanced ImmuniT, Inc.
  • VP RA, QA, QC – E-Z-EM, Inc.
  • VP Clinical and Regulatory Affairs, Pandex Div., Baxter Healthcare
  • Mgr. Clinical and Regulatory Affairs G.D. Searle, Medical products groups.
  • Co-inventor of global patents for the treatment of Cytokine Mediated Inflammatory Diseases, Immediate Early Gene Expression and Potential Therapies to Treat Allostatic Stress.
  • 25 years of experience in the pharmaceutical and CRO industry, in Business Development, Operations and Corporate Development, assignments and experience have focused on revenue generation, corporate infrastructure and geographic expansion.
  • Senior and executive capacities within industry, academia and non-profit research institutions such as Quintiles, PPD, PRA, Duke and the David H Murdoch Research Institute, responsible for leading global business development teams focused on revenue production and new product development through organic, acquisition, product licensing and strategic alliances.
  • Co-founder of two biomarker and diagnostic development companies, Clingenics and Gentris, with primary focus on fund raise, strategic alliances and global expansion, opening facilities in Taiwan and China.
  • Opened laboratories and manufacturing facilities in the US, Europe, Asia and India.